Surgery Partners (SGRY) Net Income towards Common Stockholders (2014 - 2026)

Surgery Partners has disclosed Net Income towards Common Stockholders across 13 years of filings, most recently posting -$2.1 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$2.1 million, down 600.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $97.1 million (up 902.48% YoY), and the FY2025 annual result was $98.9 million, up 691.2% from the prior year.
• Net Income towards Common Stockholders came in at -$2.1 million for Q1 2026 at Surgery Partners, down from $29.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $57.7 million in Q2 2023 to a low of -$46.6 million in Q4 2024.
• The 5-year median for Net Income towards Common Stockholders is $12.2 million (2022), against an average of $11.2 million.
• Across the five-year window, Net Income towards Common Stockholders plunged 23300.0% in 2022 and jumped 1925.0% in 2024, its largest moves.
• Surgery Partners' Net Income towards Common Stockholders stood at -$23.4 million in 2022, then soared by 299.57% to $46.7 million in 2023, then tumbled by 199.79% to -$46.6 million in 2024, then surged by 162.23% to $29.0 million in 2025, then slumped by 107.24% to -$2.1 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$2.1 million (Q1 2026), $29.0 million (Q4 2025), and $25.3 million (Q3 2025), per Business Quant data.